- Home
- TYRA vs CRNC Comparison
TYRA vs CRNC Comparison
Compare TYRA & CRNC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TYRA
- CRNC
- Stock Information
- Founded
- TYRA 2018
- CRNC 2020
- Country
- TYRA United States
- CRNC United States
- Employees
- TYRA N/A
- CRNC N/A
- Industry
- TYRA Biotechnology: Pharmaceutical Preparations
- CRNC EDP Services
- Sector
- TYRA Health Care
- CRNC Technology
- Exchange
- TYRA Nasdaq
- CRNC Nasdaq
- Market Cap
- TYRA 422.6M
- CRNC 445.8M
- IPO Year
- TYRA 2021
- CRNC N/A
- Fundamental
- Price
- TYRA $8.92
- CRNC $7.59
- Analyst Decision
- TYRA Strong Buy
- CRNC Buy
- Analyst Count
- TYRA 6
- CRNC 8
- Target Price
- TYRA $30.50
- CRNC $8.41
- AVG Volume (30 Days)
- TYRA 353.6K
- CRNC 1.1M
- Earning Date
- TYRA 05-08-2025
- CRNC 05-07-2025
- Dividend Yield
- TYRA N/A
- CRNC N/A
- EPS Growth
- TYRA N/A
- CRNC N/A
- EPS
- TYRA N/A
- CRNC N/A
- Revenue
- TYRA N/A
- CRNC $244,065,000.00
- Revenue This Year
- TYRA N/A
- CRNC N/A
- Revenue Next Year
- TYRA N/A
- CRNC $9.23
- P/E Ratio
- TYRA N/A
- CRNC N/A
- Revenue Growth
- TYRA N/A
- CRNC N/A
- 52 Week Low
- TYRA $6.42
- CRNC $2.34
- 52 Week High
- TYRA $29.60
- CRNC $27.50
- Technical
- Relative Strength Index (RSI)
- TYRA 45.95
- CRNC 41.59
- Support Level
- TYRA $8.23
- CRNC $7.08
- Resistance Level
- TYRA $8.80
- CRNC $7.85
- Average True Range (ATR)
- TYRA 0.70
- CRNC 0.74
- MACD
- TYRA 0.19
- CRNC 0.11
- Stochastic Oscillator
- TYRA 75.30
- CRNC 64.33
About TYRA Tyra Biosciences Inc.
Tyra Biosciences Inc is a clinical-stage biotechnology company focused on developing next-generation precision medicines that target large opportunities in Fibroblast Growth Factor Receptor (FGFR) biology. The company's in-house precision medicine platform, SNAP, enables rapid and precise drug design through iterative molecular SNAPshots that help to design and predict which product candidates may demonstrate the highest potency, selectivity, and tolerability in the clinic. The various drug candidates in the company's product pipeline are TYRA-300, TYRA-200, and TYRA-430: three clinical-stage, novel small molecules designed to overcome the toxicity and resistance liabilities of first-generation pan-FGFR inhibitors.
About CRNC Cerence Inc.
Cerence Inc is a United States-based software company. It is involved in developing mobility-based solutions for drivers and their cars. The customers include all automobile original equipment manufacturers, or OEMs, or their tier 1 suppliers. The company's revenue is generated by selling software licenses and cloud-connected services. Geographically, it derives a majority of its revenue from the United States and also has a presence in Other Americas; Germany; Other Europe, the Middle East, Africa; Japan, and Other Asia-Pacific.